| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.0033 | 1 |